Detalles de la búsqueda
1.
[Early hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: the risk factors and long-time survival].
Zhonghua Gan Zang Bing Za Zhi
; 19(7): 498-501, 2011 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-22152239
2.
[Transjugular intrahepatic portosystemic shunt and combination with percutaneous transhepatic or transsplenic approach for the treatment of portal vein thrombosis with or without cavernomatous transformation].
Zhonghua Yi Xue Za Zhi
; 89(22): 1549-52, 2009 Jun 09.
Artículo
en Zh
| MEDLINE | ID: mdl-19953883
3.
Brain white matter fiber tracts involved in post-transjugular intrahepatic portosystemic shunt hepatic myelopathy.
Neuroreport
; 28(17): 1164-1169, 2017 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28953093
4.
Prospective randomized clinical trial of two drug delivery pathway in the treatment of inoperable advanced pancreatic carcinoma.
Chin J Dig Dis
; 7(1): 45-8, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16412037
5.
Education and Imaging: Hepatobiliary and pancreatic: unusual venous collaterals with membranous obstruction of the inferior vena cava.
J Gastroenterol Hepatol
; 25(12): 1902, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21155187
6.
Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
World J Gastroenterol
; 20(3): 774-85, 2014 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24574750
7.
Prognostic factors in non-malignant and non-cirrhotic patients with portal cavernoma: an 8-year retrospective single-center study.
World J Gastroenterol
; 19(42): 7447-54, 2013 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24259977
8.
Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: a propensity score matching study.
J Dig Dis
; 14(4): 181-90, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23324079
Resultados
1 -
8
de 8
1
Próxima >
>>